Polycomb-independent activity of EZH2 in castration resistant prostate cancer
暂无分享,去创建一个
Tao Liu | Housheng Hansen He | X Shirley Liu | Colm Morrissey | Massimo Loda | Myles Brown | M. Loda | P. Kantoff | X. Liu | R. Vessella | T. Liu | H. He | C. Morrissey | S. Balk | E. Stack | Kexin Xu | C. Cai | Z. Wu | Philip W Kantoff | A. Groner | Robert L Vessella | Edward C Stack | Kexin Xu | Zhenhua Jeremy Wu | Anna C Groner | Changmeng Cai | Steven P Balk | Myles A. Brown | X. Liu | Changmeng Cai | X. Liu
[1] S. Dhanasekaran,et al. The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.
[2] H. Drexler,et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders , 2010, Nature Genetics.
[3] D. Reinberg,et al. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27. , 2004, Genes & development.
[4] Yi Zhang,et al. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. , 2004, Current opinion in genetics & development.
[5] A. Ferrando,et al. Genetic Inactivation of the PRC2 Complex in T-Cell Acute Lymphoblastic Leukemia , 2011, Nature Medicine.
[6] R. Rosenfeld. Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[7] A. Chase,et al. Aberrations of EZH2 in Cancer , 2011, Clinical Cancer Research.
[8] J. Simon,et al. Roles of the EZH2 histone methyltransferase in cancer epigenetics. , 2008, Mutation research.